Third, tumor subsets enriched for immune markers, including cytotoxic immune genes (e.g., Prf1, Gzmb, Gzmg) and mast cell protease genes (e.g., Mcpt1, Cma1, Tpsb2). The gene discussed is CPT1B; the disease is neoplasm.